1. Dr. Dinesh S. Patel has been appointed/ elected as Executive Chairman of the Company.
2. Unaudited Standalone and Consolidated Financial Results for the Quarter / Half year ended 30th September, 2022. A copy of Unaudited Standalone and Consolidated Financial Results for the Quarter / Half year ended 30th September, 2022 together with Limited Review Report is enclosed herewith.
3. Borrowing money of Rs.70 Crores (Rupees Seventy Crores only) from Non Banking Financial Companies.
4. Agreement to Sell between Themis Medicare Limited ('Company' or 'Transferor Company') and Themis Lifestyle Private Limited ('Transferee Company')
5. Purchase of up to 9,39,597 equity shares of Gujarat Themis Biosyn Limited, a company listed on the BSE Limited from Pharmaceutical Business Group [India] Limited (PBG India) ('Acquisition')
|